LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive Account

Home News ArchiveMorgan Stanley Raises Visa Price Target to $471 From $416

Live News EQUITY FLASH L impact Oct 28, 2026, 09:37 AM UTC

Morgan Stanley Raises Visa Price Target to $471 From $416

Morgan Stanley adjusted its price target on Visa to $471 from $416.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

V

Related stories

Ono Pharma’s ONO-1110 Misses Primary Endpoints in Three Phase 2 Pain Studies M impact | EQUITY | Oct 29, 2026, 03:03 AM UTC Carter’s Q3 Results Due Tomorrow Carter’s is scheduled to report its third-quarter results tomorrow morning. M impact | EQUITY | Oct 29, 2026, 03:02 AM UTC Colgate-Palmolive (CL) reports Q3: everything you need to know ahead of earnings Consumer products company Colgate-Palmolive NYSE:CLwill be reporting results this Friday morning. Here’s what investors should know.Colgate-Palmolive met analysts’ revenue expectat H impact | EQUITY | Oct 29, 2026, 03:02 AM UTC KPIT Technologies Q2 Revenue Growth Slows to 6.5%, Wins $213 Million in Deals KPIT Technologies reported 6.5% year-on-year revenue growth in Q2 FY27 and new engagements worth $213 million. Growth in truck, off-highway and connected-vehicle businesses offset M impact | EQUITY | Oct 29, 2026, 03:02 AM UTC Schaeffler India Q3 Revenue Rises 27.4% to Rs 3,006 Crore Schaeffler India reported revenue from operations of Rs 3,005.8 crore for the quarter ended September 30, up 27.4% year over year. Rising input costs and rupee depreciation weighed M impact | EQUITY | Oct 29, 2026, 03:02 AM UTC Sellas Life Sciences shares fall 15% to $10.38 Sellas Life Sciences shares ended Wednesday 15% lower at $10.38 as the company moved closer to a key cancer-drug readout. M impact | EQUITY | Oct 29, 2026, 03:02 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.